$SLS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in SELLAS Life Sciences Group, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in SELLAS Life Sciences Group, Inc.. Get notifications about new insider transactions in SELLAS Life Sciences Group, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 20 2009 | GALE | Galena Biopharma, ... | Samarsky Dmitry | VP, Technology Deve ... | Option Exercise | A | 4.19 | 30,000 | 125,700 | 158,260 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Woolf Tod | President and CEO | Option Exercise | A | 4.19 | 48,000 | 201,120 | 420,100 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Andrikopoulos Konstantinos | VP, Legal | Option Exercise | A | 4.19 | 100,000 | 419,000 | 100,000 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | DiPalma Stephen J. | CFO, EVP, Secretary | Option Exercise | A | 4.19 | 36,218 | 151,753 | 202,646 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | DiPalma Stephen J. | CFO, EVP, Secretary | Option Exercise | A | 4.19 | 47,000 | 196,930 | 166,428 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Option Exercise | A | 4.19 | 50,000 | 209,500 | 150,000 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Pavco Pamela | VP of Pharmaceutica ... | Option Exercise | A | 4.19 | 47,000 | 196,930 | 234,137 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Option Exercise | A | 4.19 | 50,000 | 209,500 | 150,000 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 4.19 | 50,000 | 209,500 | 150,000 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Ahn Mark J | Director | Option Exercise | A | 4.19 | 50,000 | 209,500 | 150,000 | |
Jan 20 2009 | GALE | Galena Biopharma, ... | Nisi Rudolph | Director | Option Exercise | A | 4.19 | 35,500 | 148,745 | 50,000 | |
Oct 28 2008 | GALE | Galena Biopharma, ... | Khvorova Anastasia | Chief Scientific Of ... | Option Exercise | A | 10.43 | 38,348 | 399,970 | 190,000 | |
Oct 28 2008 | GALE | Galena Biopharma, ... | Khvorova Anastasia | Chief Scientific Of ... | Option Exercise | A | 10.43 | 151,652 | 1,581,730 | 190,000 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | Woolf Tod | President and CEO | Option Exercise | A | 7.50 | 55,106 | 413,295 | 55,106 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | Samarsky Dmitry | VP, Technology Deve ... | Option Exercise | A | 7.50 | 22,699 | 170,243 | 22,699 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | Pavco Pamela | VP of Pharmaceutica ... | Option Exercise | A | 7.50 | 41,826 | 313,695 | 41,826 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | DiPalma Stephen J. | CFO and Secretary | Option Exercise | A | 7.50 | 19,428 | 145,710 | 19,428 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Option Exercise | A | 7.50 | 25,000 | 187,500 | 25,000 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | Hillsberg Sanford | Director | Option Exercise | A | 7.50 | 25,000 | 187,500 | 25,000 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | GALLIKER STEPHEN S | Director | Option Exercise | A | 7.50 | 25,000 | 187,500 | 25,000 | |
Apr 22 2008 | GALE | Galena Biopharma, ... | Ahn Mark J | Director | Option Exercise | A | 7.50 | 25,000 | 187,500 | 25,000 | |
Mar 13 2008 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Buy | J | 0.00 | 200,594 | 0 | 209,584 | 9 K to 209.6 K (+2,231.30 %) |
Mar 13 2008 | GALE | Galena Biopharma, ... | KRIEGSMAN STEVEN A | Director | Buy | J | 0.00 | 8,990 | 0 | 8,990 | 0 to 9 K |
Mar 12 2008 | GALE | Galena Biopharma, ... | CYTRX CORP | 10% Owner | Sell | J | 0.00 | 27,694 | 0 | 6,268,881 | 6.3 M to 6.3 M (-0.44 %) |
Mar 12 2008 | GALE | Galena Biopharma, ... | CYTRX CORP | 10% Owner | Sell | J | 0.00 | 4,526,624 | 0 | 6,296,575 | 10.8 M to 6.3 M (-41.82 %) |